Skip to main content
    H

    HCA Healthcare, Inc. (HCA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $501.03
    -10.75 (-2.10%)

    Market Cap: $106.91B

    Last updated: Nov 17, 2026 at 4:34 PM ET

    HCA Healthcare, Inc. (HCA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    HCA Healthcare (HCA) has a market cap of $106.91B and an enterprise value of $156.49B. Its share count is down 7.86% from a year earlier. Its return on invested capital of 22.82% compares with a 10.68% median across 10 similar companies.

    Total Valuation

    Enterprise value is 46.38% above the market cap, as debt exceeds cash.

    Market Cap$106.91B
    Enterprise Value$156.49B
    Latest price (Nov 17, 2026)$501.03

    Key Dates

    The next earnings report is expected on Jan 25, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 15, 2026.

    Next Earnings DateJan 25, 2027 (expected)
    Last Earnings DateOct 27, 2026
    Next Ex-Dividend DateDec 15, 2026
    Next Payment DateDec 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 2.70% in the quarter ended Sep 30, 2026 and shrank 8.58% a year over 2 years.

    Shares Outstanding214.59M
    Shares Change (YoY)-7.86%
    Shares Change (QoQ)-2.70%
    Share Count Growth (2Y CAGR)-8.58%

    Valuation Ratios

    The price to sales ratio is 1.4x. Its year-end P/E ranged from 10.8x to 16.6x from 2016 to 2025.

    P/E Ratio16.7x
    Forward P/E16.4x
    P/S Ratio1.4x
    Forward P/S1.4x
    P/FCF Ratio18.0x
    P/OCF Ratio9.6x
    PEG Ratio1.7

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 9.8x EBITDA and 26.3x free cash flow.

    EV / Earnings20.1x
    EV / Sales2.0x
    EV / EBITDA9.8x
    EV / EBIT12.8x
    EV / FCF26.3x

    Price Statistics

    The stock is up 6.54% over 52 weeks and trades 9.68% above its 50-day average.

    Beta (1Y)0.25
    52-Week Change+6.54%
    1-Month Change+10.15%
    3-Month Change+23.31%
    6-Month Change+24.27%
    5-Year Change+88.93%
    10-Year Change+518.31%
    Total Return (1Y)+7.19%
    Total Return (3Y CAGR)+27.57%
    Total Return (5Y CAGR)+16.48%
    Return vs SPY (1Y)-6.25%
    Max Drawdown (1Y)-33.74%
    Max Drawdown (3Y)-33.74%
    Sharpe Ratio (1Y)0.16
    Correlation with SPY (1Y)0.10
    50-Day Average$456.81
    200-Day Average$444.57
    52-Week Range$353.34 to $553.56
    RSI (14 Days)59.5
    Average Volume (20 Days)1.41M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.82x current liabilities.

    Current Ratio0.82x
    Quick Ratio0.74x
    Debt / EBITDA3.16x
    Debt / FCF8.45x
    Interest Coverage5.16x

    Returns and Efficiency

    Return on invested capital is 22.82% over the last 12 months, against a 5-year average of 22.77%.

    Return on Assets (ROA)12.29%
    Return on Invested Capital (ROIC)22.82%
    Return on Capital Employed (ROCE)27.92%
    ROA (5Y Average)12.62%
    ROIC (5Y Average)22.77%
    Asset Turnover1.28x
    Inventory Turnover26.94x
    Receivables Turnover6.62x
    Cash Conversion Cycle29 days

    Taxes

    Income tax took 20.60% of pretax income over the last 12 months.

    Income Tax (TTM)$2.02B
    Effective Tax Rate20.60%

    Scores

    HCA has an Altman Z-Score of 2.58, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score2.58
    Altman Z ZoneGrey
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $78.70B over the last 12 months is up 5.82% from the 12 months before.

    Revenue$78.70B
    Revenue Growth (YoY)+5.82%
    Gross Profit$33.82B
    Operating Income$12.19B
    Pretax Income$9.82B
    Net Income$7.80B
    EBITDA$15.98B
    EBIT$12.19B
    Reported EPS (TTM)$29.97

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$908.00M
    Total Debt$50.49B
    Net Debt$49.59B
    Net Debt Per Share$231.07
    Working Capital-$3.56B
    Shareholder Equity-$8.08B
    Tangible Book Value-$19.28B
    Total Assets$63.45B
    Total Liabilities$68.05B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $5.20B of capital spending, operating cash flow left $5.97B of free cash flow.

    Operating Cash Flow$11.17B
    Capital Expenditures$5.20B
    Free Cash Flow$5.97B
    FCF Per Share$27.59
    Depreciation and Amortization$3.79B
    Dividends Paid$1.45B
    Share Repurchases$9.16B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 15.49%, against a 5-year average of 16.44%.

    Gross Margin42.97%
    Operating Margin15.49%
    Pretax Margin12.48%
    Net Margin9.91%
    EBITDA Margin20.30%
    EBIT Margin15.49%
    FCF Margin7.59%
    Gross Margin (5Y Average)55.12%
    Operating Margin (5Y Average)16.44%
    Net Margin (5Y Average)10.72%

    Growth

    Revenue grew 7.87% a year over 3 years, and EPS 18.69% a year.

    Revenue Growth (3Y CAGR)+7.87%
    Revenue Growth (5Y CAGR)+7.97%
    EPS Growth (3Y CAGR)+18.69%
    EPS Growth (5Y CAGR)+23.39%
    FCF Growth (3Y CAGR)+23.07%
    FCF Growth (5Y CAGR)+3.76%
    Operating Income Growth (3Y CAGR)+5.27%

    Revenue and profit by year

    Dividends and Yields

    HCA pays out 5.88% of earnings as dividends.

    Dividend Per Share (Annual)$3.12
    Dividend Yield0.62%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+8.74%
    Dividend Growth (5Y CAGR)+30.19%
    Payout Ratio5.88%
    FCF Payout Ratio24.29%
    Earnings Yield5.99%
    FCF Yield5.56%
    Buyback Yield8.52%
    Shareholder Yield9.87%

    Full dividend history

    Peer Position

    Against 10 similar companies, HCA has the 6th highest P/E and the 4th highest P/S.

    P/E Ratio16.7x vs 19.5x median
    P/S Ratio1.4x vs 1.0x median
    ROIC22.82% vs 10.68% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.82% vs +6.48% median
    Dividend Yield0.62% vs 0.21% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.93% and EPS growth at 5.24% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.93%
    EPS Growth Forecast (2Y CAGR)+5.24%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HCA

    What is HCA's market cap?

    HCA Healthcare has a market cap of $106.91B. Its enterprise value, which adds debt and subtracts cash, is $156.49B.

    What is HCA's P/E ratio?

    HCA Healthcare has a trailing P/E ratio of 16.7x and a forward P/E of 16.4x.

    How many shares of HCA are outstanding?

    HCA Healthcare has 214.59M shares outstanding. The count is down 7.86% from a year earlier.

    Does HCA pay a dividend?

    Yes. HCA Healthcare pays $3.12 a share a year, a dividend yield of 0.62%.

    How much debt does HCA have?

    HCA Healthcare has $50.49B of total debt and $908.00M of cash and equivalents, a net debt position of $49.59B.